The Impact of Free Fatty Acid (FFA-) Suppression on Myocardial Lipids and Function in Patients With Type 2 Diabetes (HYPOTESIS)
HYPOglycemia Linked to Cardiac sTEatoSIS? - Identifying Mechanisms That Explain Adverse Cardiovascular Outcome Associated With Intensive Glucose Control in Patients With Diabetes (HYPOTESIS)
There is evidence that inhibition of FFA-release by acipimox is associated with a significant decrease in myocardial lipid content (MYCL) as well as the ejection fraction (as a marker of systolic left ventricular function) in healthy subjects, indicating, that the heart is dependent on a constant supply of free fatty acids in order to guarantee normal cardiac function, and it further indicates, that the heart is not able to cover its energy demand by switching to glucose oxidation.
Since that phenomenon, better known as "metabolic inflexibility" has been mainly described in patients with diabetes, we aim to investigate the impact of FFA-inhibition on MYCL and cardiac function in patients with overt type 2 diabetes.
研究概览
研究类型
注册 (实际的)
阶段
- 阶段2
- 第三阶段
联系人和位置
学习地点
-
-
-
Vienna、奥地利、1090
- Division of Endocrinology and Metabolism, Internal Medicine III, Medical University of Vienna
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Type 2 Diabetes
- HbA1C >6%
Exclusion Criteria:
- Insulin therapy (except: BOT=basal supported oral therapy)
- Known heart disease including coronary artery disease, cardiomyopathy, history of cardiac surgery
- Known intolerance against niacins
- Known contra-indications against magnetic resonance (MR-) examinations
学习计划
研究是如何设计的?
设计细节
- 主要用途:基础科学
- 分配:随机化
- 介入模型:交叉作业
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:acipimox+
250 mg at 0 and 180 minutes (one day)
|
|
|
安慰剂比较:Placebo
1 Tablet at 0 and 180 minutes (one day)
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
MYCL
大体时间:180 minutes
|
Intramyocardiocellular lipid content (MYCL) before and after administration of acipimox or placebo
|
180 minutes
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Ejection Fraction
大体时间:180 minutes
|
Left ventricular ejection fraction before and after administration of acipimox or placebo
|
180 minutes
|
其他结果措施
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Stroke Volume
大体时间:180 minutes
|
Stroke volume before and after administration of acipimox or placebo
|
180 minutes
|
合作者和调查者
调查人员
- 首席研究员:Michael Krebs, Prof.MD、Medical University of Vienna, Dept. of Internal Medicine III, Division of Endocrinology and Metabolism
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.